TGFB1 and myocardial ischemia: Taken together, when systemic TGFβ inhibition is initiated before or at the onset of myocardial ischemia, detrimental effects are observed, most likely due to TGFβ signaling-mediated suppression of inflammation, activation of fibroblasts, and generation of extracellular matrix.